A comprehensive review of arginine kinase proteins: What we need to know?

被引:1
|
作者
Vasconcellos, Brenda Martins [1 ]
Ribeiro, Victor Guimaraes [1 ]
Campos, Naysha do Nascimento [1 ]
Roma Mota, Luis Guilherme da Silva [1 ]
Moreira, Monica Ferreira [1 ,2 ]
机构
[1] Univ Fed Rio Janeiro, Inst Quim, BR-21941909 Rio De Janeiro, RJ, Brazil
[2] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil
关键词
Arginine kinase enzyme; Insect; Phosphoarginine; AMINO-ACID-SEQUENCE; TRYPANOSOMA-CRUZI; PHOSPHAGEN KINASE; CRYSTAL-STRUCTURE; HELICOVERPA-ARMIGERA; ALLERGENIC PROTEINS; COCKROACH ALLERGEN; TOXOCARA-CANIS; LOBSTER MUSCLE; EVOLUTION;
D O I
10.1016/j.bbrep.2024.101837
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme arginine kinase (AK), EC 2.7.3.3, catalyzes the reversible phosphorylation of arginine with adenosine triphosphate, forming phosphoarginine, which acts as an energy reservoir due to its high-energy phosphate content that can be rapidly transferred to ADP for ATP renewal. It has been proposed that AK should be associated with some ATP biosynthesis mechanisms, such as glycolysis and oxidative phosphorylation. Arginine kinase is an analogue of creatine kinase found in vertebrates. A literature survey has recovered the physicochemical and structural characteristics of AK. This enzyme is widely distributed in invertebrates such as protozoa, bacteria, porifera, cnidaria, mollusca, and arthropods. Arginine kinase may be involved in the response to abiotic and biotic stresses, being up regulated in several organisms and controlling energy homeostasis during environmental changes. Additionally, phosphoarginine plays a role in providing energy for the transport of protozoa, the beating of cilia, and flagellar movement, processes that demand continuous energy. Arginine kinase is also associated with allergies to shellfish and arthropods, such as shrimp, oysters, and cockroaches. Phenolic compounds such as resveratrol, which decrease AK activity by 50 % in Trypanosoma cruzi, inhibit the growth of the epimastigote and trypomastigote forms, making them a significant target for the development of medications for Chagas Disease treatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] What we know about Mars from its impact craters
    Barlow, Nadine G.
    GEOLOGICAL SOCIETY OF AMERICA BULLETIN, 2010, 122 (5-6) : 644 - 657
  • [42] Emerging Influenza D Virus Threat: What We Know so Far!
    Asha, Kumari
    Kumar, Binod
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [43] What do we know about ribosomal RNA methylation in Escherichia coli?
    Sergeeva, O. V.
    Bogdanov, A. A.
    Sergiev, P. V.
    BIOCHIMIE, 2015, 117 : 110 - 118
  • [44] INTERLEUKIN 15-WHAT DO WE KNOW? THE STRUCTURE, RECEPTORS AND INHIBITORS
    Zyzynska-Granica, Barbara
    POSTEPY BIOLOGII KOMORKI, 2011, 38 (03) : 435 - 452
  • [45] From Correlation to Causation: What Do We Need in the Historical Sciences?
    Ebach, Malte C.
    Michael, Michaelis S.
    ACTA BIOTHEORETICA, 2016, 64 (03) : 241 - 262
  • [46] Bacillus spore germination: Knowns, unknowns and what we need to learn
    Christie, Graham
    Setlow, Peter
    CELLULAR SIGNALLING, 2020, 74
  • [47] How the Orthodox Features of Orthopoxviruses Led to an Unorthodox Mpox Outbreak: What We've Learned, and What We Still Need to Understand
    Brooks, John T.
    Reynolds, Mary G.
    Torrone, Elizabeth
    McCollum, Andrea
    Spicknall, Ian H.
    Gigante, Crystal M.
    Li, Yu
    Satheshkumar, Panayampalli S.
    Quilter, Laura A. S.
    Rao, Agam K.
    O'Shea, Jesse
    Guagliardo, Sarah Anne J.
    Townsend, Michael
    Hutson, Christina L.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 : S121 - S131
  • [48] How Genomics Is Changing What We Know About the Evolution and Genome of Bordetella pertussis
    Ring, Natalie
    Abrahams, Jonathan S.
    Bagby, Stefan
    Preston, Andrew
    MacArthur, Iain
    PERTUSSIS INFECTION AND VACCINES: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 12, 2019, 1183 : 1 - 17
  • [49] What Do We Know about the Patterns and Determinants of Female Entrepreneurship across Countries?
    Minniti, Maria
    Naude, Wim
    EUROPEAN JOURNAL OF DEVELOPMENT RESEARCH, 2010, 22 (03): : 277 - 293
  • [50] What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?
    Amigo, M-C
    LUPUS, 2014, 23 (12) : 1259 - 1261